Search

Your search keyword '"Carboplatin -- Research"' showing total 4 results
Start Over Descriptor "Carboplatin -- Research" Publisher syndigate media inc.
4 results on '"Carboplatin -- Research"'

1. Seagen and Genmab Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2021

Subjects
Genmab A/S, Carboplatin -- Research, Oncology, Experimental, Metastasis -- Research, Diseases -- Relapse, Cervical cancer -- Research, Cancer -- Research, Pharmaceutical industry -- Research, Business, international, Law
Abstract

Seagen Inc. (Nasdaq: SGEN) and Genmab A/S (Nasdaq: GMAB) today presented interim data from two cohorts of the phase 1b/2 innovaTV 205 multi-cohort, open-label trial of tisotumab vedotin in recurrent [...]

Published
2021

2. ECOG-ACRIN research highlights at ASCO 2021

Subjects
Carboplatin -- Research, Oncology, Experimental, Papillomavirus infections -- Research, Chemotherapy -- Research, Cancer -- Chemotherapy -- Research, Business, international, Law
Abstract

New research results for patients with breast and HPV-associated throat cancers are the highlights among 23 presentations by ECOG-ACRIN Cancer Research Group researchers at the 2021 American Society of Clinical [...]

Published
2021

3. Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer

Subjects
Roche Holding AG, Atezolizumab -- Research, Bevacizumab -- Research, Cancer research, Carboplatin -- Research, Ovarian cancer -- Research -- Care and treatment, Business, international, Law, Tecentriq (Medication) -- Research, Avastin (Medication) -- Research
Abstract

(GlobeNewswire) - Basel, 13 July 2020 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMagyn050 study showed that the addition of Tecentriq (atezolizumab) to Avastin (bevacizumab), [...]

Published
2020

4. Genentech Provides Update on Phase III Study of Tecentriq in Women With Advanced-stage Ovarian Cancer

Subjects
Atezolizumab -- Research, Bevacizumab -- Research, Cancer research, Carboplatin -- Research, Biological products industry -- Research, Ovarian cancer -- Research -- Care and treatment, Business, international, Law, Tecentriq (Medication) -- Research, Avastin (Medication) -- Research
Abstract

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III IMagyn050 study showed that the addition of Tecentriq (atezolizumab) to Avastin (bevacizumab), [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results